Cayuga
New York
About Cayuga
Cayuga develops novel hemostatic drugs and devices using biomimetic polyphosphate technology to control bleeding and accelerate healing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $250.0K
- Funding stage: Seed
- Last round: Pre-Seed (Oct 2020)
- Website: cayugabio.tech
- Phone: 9292849536
Industries & Categories
Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/cayuga-140123 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.